EAPC Premium Access

Inflammation in atherosclerosis: translating science into practicable solutions.

Event: EuroPrevent 2018
Topic: Secondary Prevention
Session type: Satellite Symposium
Sponsored by Novartis Pharma AG
Date: 20 April 2018
Time: 12:45 - 13:45

Session

5 presentations in this session

Welcome and introduction - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)
Thumbnail

Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor P. Libby (Boston, US)
Thumbnail

Clinical residual cardiovascular risk: what are the markers?

Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

Advancing standard of care in post-myocardial infarction (MI) patients with elevated high sensitivity C-reactive protein (hsCRP).

Speaker: Professor U. Landmesser (Berlin, DE)
Speaker: Professor P. Libby (Boston, US)
Speaker: Professor W. Koenig (Munich, DE)
Thumbnail

Summary and closure - Inflammation in atherosclerosis: translating science into practicable solutions.

Speaker: Professor U. Landmesser (Berlin, DE)
Thumbnail

7 speakers from this session

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
34 presentations
1 follower

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
28 presentations
2 followers

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
34 presentations
1 follower

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
28 presentations
2 followers

Professor Wolfgang Koenig

German Heart Center of Munich,, Munich (Germany)
20 presentations
0 follower

Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)
34 presentations
1 follower

This platform is supported by

logo Novo Nordisk